Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_assertion type Assertion NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_head.
- NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_assertion description "[More potent synthetic PPAR ligands, including the fibrates and thiazolidinediones, have proven effective in the treatment of dyslipidemia and diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_provenance.
- NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_assertion evidence source_evidence_literature NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_provenance.
- NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_assertion SIO_000772 11818483 NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_provenance.
- NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_assertion wasDerivedFrom befree-20140225 NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_provenance.
- NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_assertion wasGeneratedBy ECO_0000203 NP421345.RA3clUqDgnINhHvdDKGU3glF6zMzejQ3_qmSEyG1bMUEY130_provenance.